ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

May 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-05-14

Reporting Person: PERRY MICHAEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-14	Common Stock	M	7000	$4.75	Acquired	15000	Direct
2020-05-14	Common Stock	M	5000	$2.01	Acquired	20000	Direct
2020-05-14	Common Stock	M	15000	$2.19	Acquired	35000	Direct
2020-05-14	Common Stock	M	10000	$2.62	Acquired	45000	Direct
2020-05-14	Common Stock	M	15000	$5.19	Acquired	60000	Direct
2020-05-14	Common Stock	M	25000	$4.20	Acquired	85000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-14	Common Stock (right to buy)	$4.75	M	7000	Disposed	2023-09-21	Common Stock (7000)	Direct
2020-05-14	Common Stock (right to buy)	$2.01	M	5000	Disposed	2023-05-06	Common Stock (5000)	Direct
2020-05-14	Common Stock (right to buy)	$2.19	M	15000	Disposed	2023-03-21	Common Stock (15000)	Direct
2020-05-14	Common Stock (right to buy)	$2.62	M	10000	Disposed	2022-09-28	Common Stock (10000)	Direct
2020-05-14	Common Stock (right to buy)	$5.19	M	15000	Disposed	2022-02-16	Common Stock (15000)	Direct
2020-05-14	Common Stock (right to buy)	$4.20	M	25000	Disposed	2021-12-22	Common Stock (25000)	Direct

Footnotes

F1: Option vested entirely on the one year anniversary of the grant date.

F2: Represents first vesting date. Option vested over four years from date of grant.